SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 6,960.00
+230.00 (3.42%)
Last updated: Jul 17, 2025
SyntekaBio Company Description
SyntekaBio, Inc. operates as an artificial intelligence new drug development company based on genomic big data primarily in South Korea.
It derives new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology.
The company also researches and develops biomarker detection for individual cancer drug screening, disease susceptibility, immune typing, pharmacogenomic typing, and multi-omics information-based drug side effect prediction technology.
The company was founded in 2009 and is headquartered in Daejeon, South Korea.
SyntekaBio, Inc.
| Country | South Korea |
| Founded | 2009 |
| Industry | Computer Programming, Data Processing, And Other Computer Related Services |
Contact Details
Address: 1903, 1, Expo Tower Daejeon South Korea | |
| Phone | 82 70 7663 0958 |
| Website | syntekabio.com |
Stock Details
| Ticker Symbol | 226330 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 7370 |